vs
Side-by-side financial comparison of JBG SMITH Properties (JBGS) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($226.2M vs $127.6M, roughly 1.8× JBG SMITH Properties). USANA HEALTH SCIENCES INC runs the higher net margin — 0.1% vs -35.7%, a 35.8% gap on every dollar of revenue. On growth, JBG SMITH Properties posted the faster year-over-year revenue change (-2.5% vs -10.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (-0.4% CAGR vs -6.3%).
JBG SMITH PropertiesJBGSEarnings & Financial Report
JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
JBGS vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $127.6M | $226.2M |
| Net Profit | $-45.5M | $180.0K |
| Gross Margin | — | 78.2% |
| Operating Margin | -47.5% | 1.7% |
| Net Margin | -35.7% | 0.1% |
| Revenue YoY | -2.5% | -10.0% |
| Net Profit YoY | 24.0% | -74.0% |
| EPS (diluted) | $-0.76 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $127.6M | $226.2M | ||
| Q3 25 | $123.9M | $213.7M | ||
| Q2 25 | $126.5M | $235.8M | ||
| Q1 25 | $120.7M | $249.5M | ||
| Q4 24 | $130.8M | $213.6M | ||
| Q3 24 | $136.0M | $200.2M | ||
| Q2 24 | $135.3M | $212.9M | ||
| Q1 24 | $145.2M | $227.8M |
| Q4 25 | $-45.5M | $180.0K | ||
| Q3 25 | $-28.6M | $-6.5M | ||
| Q2 25 | $-19.2M | $9.7M | ||
| Q1 25 | $-45.7M | $9.4M | ||
| Q4 24 | $-59.9M | $4.5M | ||
| Q3 24 | $-27.0M | $10.6M | ||
| Q2 24 | $-24.4M | $10.4M | ||
| Q1 24 | $-32.3M | $16.5M |
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | 81.1% | ||
| Q1 24 | — | 81.1% |
| Q4 25 | -47.5% | 1.7% | ||
| Q3 25 | -27.5% | 0.6% | ||
| Q2 25 | -18.4% | 7.1% | ||
| Q1 25 | -44.7% | 6.3% | ||
| Q4 24 | -53.6% | 3.8% | ||
| Q3 24 | -22.4% | 7.8% | ||
| Q2 24 | -24.3% | 8.4% | ||
| Q1 24 | -30.1% | 10.8% |
| Q4 25 | -35.7% | 0.1% | ||
| Q3 25 | -23.1% | -3.1% | ||
| Q2 25 | -15.2% | 4.1% | ||
| Q1 25 | -37.9% | 3.8% | ||
| Q4 24 | -45.8% | 2.1% | ||
| Q3 24 | -19.8% | 5.3% | ||
| Q2 24 | -18.0% | 4.9% | ||
| Q1 24 | -22.2% | 7.3% |
| Q4 25 | $-0.76 | $-0.10 | ||
| Q3 25 | $-0.48 | $-0.36 | ||
| Q2 25 | $-0.29 | $0.52 | ||
| Q1 25 | $-0.56 | $0.49 | ||
| Q4 24 | $-0.70 | $0.23 | ||
| Q3 24 | $-0.32 | $0.56 | ||
| Q2 24 | $-0.27 | $0.54 | ||
| Q1 24 | $-0.36 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.3M | $158.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | — |
| Total Assets | $4.4B | $742.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.3M | $158.4M | ||
| Q3 25 | $64.4M | $145.3M | ||
| Q2 25 | $61.4M | $151.3M | ||
| Q1 25 | $81.3M | $179.6M | ||
| Q4 24 | $145.8M | $181.8M | ||
| Q3 24 | $137.0M | $364.9M | ||
| Q2 24 | $163.5M | $332.4M | ||
| Q1 24 | $220.5M | $328.3M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $528.1M | ||
| Q2 25 | $1.3B | $531.1M | ||
| Q1 25 | $1.6B | $529.8M | ||
| Q4 24 | $1.8B | $532.1M | ||
| Q3 24 | $1.9B | $533.1M | ||
| Q2 24 | $2.0B | $512.2M | ||
| Q1 24 | $2.1B | $500.0M |
| Q4 25 | $4.4B | $742.9M | ||
| Q3 25 | $4.4B | $726.6M | ||
| Q2 25 | $4.5B | $734.5M | ||
| Q1 25 | $4.7B | $746.6M | ||
| Q4 24 | $5.0B | $748.2M | ||
| Q3 24 | $5.2B | $671.3M | ||
| Q2 24 | $5.3B | $631.4M | ||
| Q1 24 | $5.4B | $629.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.3M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.3M | — | ||
| Q3 25 | $8.9M | $-2.0M | ||
| Q2 25 | $18.8M | $12.2M | ||
| Q1 25 | $12.9M | $15.5M | ||
| Q4 24 | $129.4M | $5.8M | ||
| Q3 24 | $26.4M | $29.5M | ||
| Q2 24 | $23.8M | $8.0M | ||
| Q1 24 | $37.0M | $17.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-5.2M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $12.7M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $27.1M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $14.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 6.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
